期刊文献+

四川地区隐球菌临床分离株基因型和耐药性分析 被引量:6

Genotypes and in vitro Antifungal Susceptibility of Cryptococcus Isolates in Sichuan Province
原文传递
导出
摘要 目的了解四川地区隐球菌临床分离株基因分型及体外临床常用抗真菌药物敏感性情况。方法采用针对URA5基因PCR产物的限制性片段长度多态性(RFLP)方法对收集自我校华西医院的92株隐球菌临床分离株进行基因分型;采用E-test法检测临床常用抗真菌药物两性霉素B(AMB)、氟胞嘧啶(FC)、氟康唑(FCA)、伊曲康唑(ITR)和伏立康唑(VRC)对隐球菌分离株的最低抑菌浓度(MIC)范围,并计算其MIC50、MIC90。结果92株隐球菌中,91株为新生隐球菌VNⅠ型,1株为格特隐球菌VGⅡ型。5种抗真菌药物对92株隐球菌临床株的MIC值范围、MIC50、MIC90值分别如下:两性霉素B为〈0.002~2μg/mL、0.19μg/mL和0.75μg/mL;氟胞嘧啶为0.5~〉32μg/mL、4μg/mL和8μg/mL;氟康唑为0.5~32μg/mL、3μg/mL和8μg/mL;伊曲康唑为0.064~2μg/mL、0.5μg/mL和1.5μg/mL;伏立康唑为0.004~0.19μg/mL、0.047μg/mL和0.094μg/mL。其中3株(3.3%)对两性霉素B耐药,4株(4.3%)对氟胞嘧啶耐药,25株(27.2%)对伊曲康唑耐药,未发现对氟康唑耐药的菌株,所有菌株对伏立康唑敏感。格特隐球菌(1株)对氟胞嘧啶耐药,对氟康唑剂量依赖敏感。不同时间段隐球菌对5种抗真菌药物的MIC值比较,差异均具有统计学意义。随时间推移,两性霉素B及氟胞嘧啶的MIC值有所升高,唑类药物MIC值变化无规律。结论四川地区隐球菌以新生隐球菌VNⅠ型为主,存在格特隐球菌VGⅡ型。除伊曲康唑外,隐球菌对其他抗真菌药物敏感性高,仅少数菌株对两性霉素B及氟胞嘧啶耐药。 Objective To determine the genotypes and in vitro antifungal susceptibility of Cryptococcus strains isolated from Sichuan Province. Methods Ninety two clinical isolates of Cryptococcus spp. were collected from West China Hospital. Genotyping of the URA.5 gene was accomplished by restriction fragment length polymorphism. The minimum inhibitory concentrations (MIC) of the isolates to 5 antifungals, including amphotericin B, flueytosine, fluconazole, itraconazole and voriconazole were determined by agar-based E-test method. The MIC50 and MICg0 were calculated based on MICs. Results Among the 92 clinical isolates, 91 were molecular type VN I and one was VG Ⅱ. The susceptibility range, MIC50 and MIC90 of the isolates to five antifungals were as follows: (〈0. 002-2) μg/mL, 0. 19 μg/mL and 0. 75 μg/mL for amphotericin B; (0. 5-〉 32) μg/mL, 4 μg/mL and 8 μg/mL for flucytosine; (0. 5-32) μg/mL, 3μg/mL and 8 μg/mL for uconazole; (0.064-2) μg/mL, 0. 5μg/mL and 1. 5 μg/mL for itraconazole; (0. 004-0. 19) μg/mL, 0. 047 μg/mL and 0. 094 μg/mL for voriconazole. Three (3.3%) isolates were resistant to amphotericin B, 4(4.3%) to flucytosine and 25 (27.2%) to itraconazole. No isolate was resistant to flueonazole and all isolates were susceptible to voriconazole. The isolate Cryprococcus gattii was resistant to flucytosine, while S-DD was resistant to fluconazole. There were significant differences in the MICs of the strains isolated from different periods. The MICs of the isolates to amphotericin B and flucytosine increased over time. Conclusion VNI molecular type is the major genotype of Cryprococcus in Sichuan. All the agents have good in vitro activities against the tested strains except itraconazole. A few stains are resistant to amphotericin B and flucytosine.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2015年第1期82-86,共5页 Journal of Sichuan University(Medical Sciences)
关键词 隐球菌 基因分型 E-TEST 抗真菌药物敏感性 Cryptococcus Genotype E-test Antifungal susceptibility
  • 相关文献

参考文献5

二级参考文献20

  • 1翁心华,朱利平.隐球菌脑膜炎治疗的若干问题[J].中国感染与化疗杂志,2007,7(1):4-6. 被引量:5
  • 2尚茂林.抗真菌新药——伏立康唑[J].中国药房,2007,18(19):1505-1507. 被引量:13
  • 3Zhu LP, Shi YZ, Weng XH, et al. Case Reports. Pulmonary cryptococcosis associated with cryptococcal meningitis in non-AIDS patients. Mycoses, 2002, 45:111-117.
  • 4Diekema DJ, Pfaller MA, Messer SA, et al. In vitro activities of BMS-207147 against over 600 contemporary clinical bloodstream isolates of Candida species from the SENTRY Antimicrobial Surveillance Program in North America and Latin America. Antimicrob Agents Chemother, 1999, 43: 2236-2239.
  • 5Fung-Tomc JC, Huczko E, Minassian B, et al. In vitro activity of a new oral triazole, BMS-207147 (ER-30346). Antimicrob Agents Chemother, 1998, 42: 313-318.
  • 6Yamazumi T, Pfaller MA, Messer SA, et al. In vitro activities of ravuconazole (BMS-207147) against 541 clinical isolates of Cryptococcus neoformans. Antimicrob Agents Chemother, 2000, 44: 2883-2886.
  • 7Saag MS,Graybill RJ,Larsen RA,et al.Practice guidelines for the management of cryptococcal disease.Infectious Diseases Society of America.Clio Infect Dis,2000,30:710-718.
  • 8Yao Z,Liao W,Chen R.Management of cryptococcosis in non-HIV-related patients.Med Mycol,2005,43:245-251.
  • 9Trilles L,Fernandez-Torres B,Lazera Mdos S,et al.In vitro antifungal susceptibility of Cryptococcus gattii.J Clin Microbiol,2004,42:4815-4817.
  • 10Armengou A,Porcar C,Mascaro J,et al.Possible development of resistance to fluconazole during suppressive therapy for AIDS-associated cryptocoeeal meningitis.Clin Infect Dis,1996,23:1337-1338.

共引文献661

同被引文献47

引证文献6

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部